Answers are grounded in this paper and cite their sources.
Adaptive immunity necessitates the proliferation of lymphocytes. In the mouse, we have previously shown that antigen-experienced T cells that have lost their proliferative potential express the killer cell lectinlike receptor G1 (KLRG1). By using a newly generated monoclonal antibody specific for human KLRG1, we now demonstrate that expression of KLRG1 also identifies T cells in humans that are capable of secreting cytokines but that fail to proliferate after stimulation. Furthermore, our data show that proliferative incapacity of CD8 T cells correlates better with KLRG1 expression than with absence of the CD28 marker. In peripheral blood lymphocytes (PBLs) from healthy adult donors, KLRG1 was expressed on 44% +/- 14% of CD8 and 18% +/- 10% of CD4 T cells. KLRG1 expression was restricted to antigen-experienced T cells. Here, KLRG1(+) cells were preferentially found in the CCR7(-) effector T-cell pool. Besides T cells, a significant portion (approximately 50%) of human natural killer (NK) cells expressed KLRG1. Interestingly, these KLRG1(+) NK cells were found exclusively in the CD56(dim) NK-cell subset. Thus, the expression of KLRG1 identifies a subset of NK cells and antigen-experienced T cells in humans that lack proliferative capacity.
No takes yet. Share an insight, caveat, or question.
Voehringer et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: